Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-14-009679
Filing Date
2014-05-21
Accepted
2014-05-21 20:20:24
Documents
1
Period of Report
2014-05-19

Document Format Files

Seq Description Document Type Size
1 SIECZKAREK rdgdoc.html 4  
1 SIECZKAREK rdgdoc.xml 4 2744
  Complete submission text file 0001437749-14-009679.txt   3999
Mailing Address
Business Address
SIECZKAREK MARK M (Reporting) CIK: 0001188738 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 14862025

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
SIC: 2834 Pharmaceutical Preparations